Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

908 Devices Announces Significant Milestones

Published: Wednesday, August 20, 2014
Last Updated: Wednesday, August 20, 2014
Bookmark and Share
Company has expanded its office from a 7,000 square-foot R&D think tank into a 16,000 square-foot full-scale production facility.

908 Devices announced a number of significant milestones since the introduction of its flagship product, M908™, the world’s first and only handheld tool utilizing high-pressure mass spectrometry™ (HPMS) for trace-level chemical detection and identification.

The company's facility is strategically located in Boston’s Innovation District on DryDock Avenue –  an area undergoing radical transformation, attracting Boston’s most creative firms and tech companies.  The new space includes a full machine shop, analytical and R&D labs, clean room, and collaborative meeting areas,  allowing the team to create new concepts, prototypes, and manufacture product in-house, all under one roof.  The expansion to a full production facility also provides the company with flexibility as it continues to grow and penetrate new markets. By designing and manufacturing products in-house, the team will stay actively involved in every stage of development, design verification, and manufacturing quality.

Since unveiling the powerful capabilities of HPMS in March 2014 with the introduction of M908, 908 Devices has recognized significant company momentum, which includes:

• Joe Griffith being appointed Chief Financial Officer, bringing his 17-year management background in corporate and operational finance, accounting and administration to 908 Devices. Joe previously served as CFO for PerkinElmer’s Life Science & Technology division and as CAO for Caliper Life Sciences.

• Expansion to 908 Device’s science and engineering staff to ramp up product development efforts for energy, environmental, and life science markets.

• To fuel the companies continued growth, the team has increased from its seven initial founders in 2012 to 30+ employees today with an expected 50% increase in 2015.

• The company is a recipient of the Mass Life Sciences Center award, providing up to $25 million in tax incentives for companies who are committed to creating new jobs in the Commonwealth and those who currently engaged in life sciences research and development.

“2014 is a banner year for 908 Devices, marked with tremendous growth and success,” said Dr. Kevin J. Knopp, co-founder and CEO, 908 Devices. “Within the analytical instrumentation industry, there has been an incredible shift in demand from very complex catch-all laboratory systems to purpose-built and user-centric analytical tools. The momentum of M908 demonstrates that we are meeting this need and we will continue to focus on delivering the best-in-class devices and solutions for our safety and security customers to use in the field.  In addition, we see a lot of opportunity to expand our HPMS platform technology into exciting new applications, including energy, environmental monitoring, and life sciences.  We are very fortunate to have been able to assemble some incredible talent to bring the most impactful technology out-of-the-lab in order to deliver meaningful results and create simplified tools out of mass spectrometry for these industries.”

“This is an exciting time to be joining 908 Devices,” said Joe Griffith, CFO, 908 Devices. “The success of M908 combined with the recent expansion to a full-scale production facility demonstrates that 908 Devices is poised to make a huge impact on mass spectrometry in the safety and security market and beyond. This is one of the most talented, forward thinking teams in the industry and I believe I can only help to propel the company forward as we build out infrastructure and processes to support our growth and strategic initiatives. I am honored to be joining the team and look forward to contributing to the company’s continued success.”

An interview with 908 Devices' VP and CTO, Dr. Christopher D. Brown, can be found on

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

908 Devices Receives $7 Million in Series B Funding
The financing round will be used to expand the R&D team and to accelerate and commercialize 908 Devices’ initial safety and security products.
Wednesday, September 11, 2013
908 Devices’ Research Partner Presents Research on Mass Spectrometry
Advancing the rapidly evolving field of High Pressure Mass Spectrometry.
Friday, August 16, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos